Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jesus Lavado-García"'
Autor:
Jesus Lavado-García, Raul Roncero-Martin, Jose M Moran, Maria Pedrera-Canal, Ignacio Aliaga, Olga Leal-Hernandez, Sergio Rico-Martin, Maria L Canal-Macias
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190539 (2018)
The regular consumption of long-chain omega-3 polyunsaturated fatty acids (LCO3-PUFAs) results in general health benefits. The intake of LCO3-PUFAs has been reported to contribute to bone metabolism. We aimed to investigate the relationships between
Externí odkaz:
https://doaj.org/article/0aa37ee0ae444571a4957993b5e4871e
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 4, Pp 101329- (2024)
Producing recombinant adeno-associated virus (rAAV) for gene therapy via triple transfection is an intricate process involving many cellular interactions. Each of the different elements encoded in the three required plasmids—pHelper, pRepCap, and p
Externí odkaz:
https://doaj.org/article/1178c71431a243ac95027659e4a9f5b6
Autor:
Pol Pérez-Rubio, Meritxell Vendrell-Flotats, Elianet Lorenzo Romero, Kasper Enemark-Rasmussen, Laura Cervera, Francesc Gòdia, Jesús Lavado-García
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 176, Iss , Pp 116893- (2024)
Polymer-cationic mediated gene delivery is a well-stablished strategy of transient gene expression (TGE) in mammalian cell cultures. Nonetheless, its industrial implementation is hindered by the phenomenon known as cell density effect (CDE) that limi
Externí odkaz:
https://doaj.org/article/e77ee55ac09d45a6aeded7d245d74ce9
Autor:
Pol Pérez-Rubio, Jesús Lavado-García, Laia Bosch-Molist, Elianet Lorenzo Romero, Laura Cervera, Francesc Gòdia
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 1, Pp 101190- (2024)
The hitherto unexplained reduction of cell-specific productivity in transient gene expression (TGE) at high cell density (HCD) is known as the cell density effect (CDE). It currently represents a major challenge in TGE-based bioprocess intensificatio
Externí odkaz:
https://doaj.org/article/29b78a996ec14786862b2e0e1807286c
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Externí odkaz:
https://doaj.org/article/78c87dd7f8444e8cb766bd245de91b27
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Virus-like particles (VLPs) have gained interest over the last years as recombinant vaccine formats, as they generate a strong immune response and present storage and distribution advantages compared to conventional vaccines. Therefore, VLPs are bein
Externí odkaz:
https://doaj.org/article/64dedb8b800b45d587b24fa4ff7a9562
Publikováno v:
Vaccines, Vol 10, Iss 2, p 250 (2022)
Virus-like particles (VLPs) constitute a promising approach to recombinant vaccine development. They are robust, safe, versatile and highly immunogenic supra-molecular structures that closely mimic the native conformation of viruses without carrying
Externí odkaz:
https://doaj.org/article/7ed07962c504422296bc8676d9d90857